Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I3 | Q14994 | 1/20 | 0.54 |
| ▸ | DPP4 | P27487 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.49 |
| ▸ | PDE5A | O76074 | 2/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.49 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29382427 | 1.00 | NR1I3 (0.54) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL29533330 | 1.00 | NR1I3 (0.54) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL17416282 | 1.00 | NR1I3 (0.54) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL31077790 | 1.00 | NR1I3 (0.54) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL18921873 | 1.00 | NR1I3 (0.54) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL30986826 | 0.98 | NR1I3 (0.55) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL23300317 | 0.96 | NR1I3 (0.51) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL19916975 | 0.96 | NR1I3 (0.51) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL22092339 | 0.96 | NR1I3 (0.51) | NR1I3DPP4TP53NPC1RAB9A | |
| SCHEMBL30775097 | 0.96 | NR1I3 (0.51) | NR1I3DPP4TP53NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912672-B2 | Organic compound and organic electroluminescent device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11912672-B2 | Organic compound and organic electroluminescent device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| CN-114853745-A | Organic electroluminescent material and device | 环球展览公司 | 2022-08-05 | — | — | CN | disclosed |
| US-20210253542-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN SOLUS CO., LTD. (KR) | 2021-08-19 | — | — | US | disclosed |
| WO-2020027463-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 주식회사 두산 | 2020-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253542-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | OR10J3, TRPA1, TRPM4 | NR1I3 4144/4885DPP4 2086/4885TP53 4034/4885 |
| US-11912672-B2 | Organic compound and organic electroluminescent device using same | OR10J3, TRPA1, TRPM4 | NR1I3 4144/4885DPP4 2086/4885TP53 4034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.